IRIS
MORONCINI, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.116
EU - Europa 4.445
AS - Asia 4.091
SA - Sud America 1.066
AF - Africa 247
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 17.984
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.912
SG - Singapore 1.258
IT - Italia 1.136
VN - Vietnam 892
BR - Brasile 845
RU - Federazione Russa 722
CN - Cina 680
DE - Germania 443
UA - Ucraina 418
HK - Hong Kong 410
SE - Svezia 325
IE - Irlanda 311
FR - Francia 274
TR - Turchia 193
GB - Regno Unito 168
FI - Finlandia 166
DK - Danimarca 149
BD - Bangladesh 138
IN - India 112
CI - Costa d'Avorio 96
CA - Canada 91
KR - Corea 82
NL - Olanda 82
MX - Messico 73
AR - Argentina 68
PL - Polonia 55
AT - Austria 49
JP - Giappone 49
ZA - Sudafrica 48
EC - Ecuador 46
IQ - Iraq 39
MA - Marocco 39
ES - Italia 35
ID - Indonesia 34
PK - Pakistan 33
CO - Colombia 29
VE - Venezuela 22
BE - Belgio 20
CL - Cile 19
IL - Israele 18
PY - Paraguay 17
TN - Tunisia 17
UZ - Uzbekistan 17
MY - Malesia 15
PH - Filippine 15
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 11
EG - Egitto 11
LT - Lituania 11
NP - Nepal 11
DZ - Algeria 10
AL - Albania 9
JO - Giordania 9
AU - Australia 8
PE - Perù 8
RO - Romania 8
RS - Serbia 8
UY - Uruguay 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
KE - Kenya 7
PS - Palestinian Territory 7
TW - Taiwan 7
CR - Costa Rica 6
HN - Honduras 6
AZ - Azerbaigian 5
EE - Estonia 5
ET - Etiopia 5
EU - Europa 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
GR - Grecia 4
GT - Guatemala 4
HR - Croazia 4
JM - Giamaica 4
KW - Kuwait 4
LB - Libano 4
NO - Norvegia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BO - Bolivia 3
GE - Georgia 3
HU - Ungheria 3
IR - Iran 3
MD - Moldavia 3
GA - Gabon 2
KG - Kirghizistan 2
LU - Lussemburgo 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 17.954
Salva come PNG Salva come JPEG
Città #
Ashburn 1.437
Singapore 747
Chandler 621
Dallas 528
San Jose 525
Jacksonville 428
Hong Kong 398
Fairfield 334
Ho Chi Minh City 307
Dublin 305
Boardman 288
Des Moines 264
New York 225
Hanoi 195
Wilmington 190
The Dalles 188
Beijing 181
Los Angeles 169
Woodbridge 155
Houston 153
Centro 149
Lauterbourg 146
Seattle 134
Munich 133
Moscow 132
Ancona 117
Ann Arbor 115
Lawrence 108
Princeton 108
Milan 100
Abidjan 96
San Mateo 92
São Paulo 91
Cambridge 80
Hefei 80
Council Bluffs 69
Chicago 64
Santa Clara 61
Orem 59
Helsinki 55
Buffalo 53
Nuremberg 51
London 45
Redmond 45
Turin 42
Da Nang 41
Haiphong 41
Turku 38
Warsaw 38
Tokyo 37
Mexico City 35
San Diego 35
Frankfurt am Main 33
Montreal 33
Shanghai 32
Rio de Janeiro 31
Rome 31
Marche 30
Tolentino 30
Atlanta 29
Chennai 29
Johannesburg 28
Salt Lake City 26
Amsterdam 24
Brasília 23
Washington 23
Brooklyn 22
Guangzhou 21
Poplar 20
Stockholm 20
Vienna 20
Belo Horizonte 19
Denver 19
Phoenix 19
Jesi 17
Porto Alegre 17
Boston 16
Columbus 16
Pune 16
Brussels 15
Curitiba 15
Manchester 15
San Francisco 15
Tashkent 15
Wuhan 15
Florence 14
Guayaquil 14
Guarulhos 13
Sterling 13
Ankara 12
Baghdad 12
Biên Hòa 12
Bắc Ninh 12
Elk Grove Village 12
Hải Dương 12
Jiaxing 12
Falls Church 11
Kilburn 11
Quito 11
Toronto 11
Totale 11.044
Salva come PNG Salva come JPEG
Nome #
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 249
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud'€™s phEnomenon (SUNSHINE survey) 242
The value of admission Troponin I to predict outcomes in suspected infections in elderly patients admitted in Internal Medicine: results from the SOFA-T collaboration, a multi-center study 213
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 209
The first outstanding 50 years of “Università Politecnica delle Marche”: Research achievements in life sciences 197
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 190
Atrial Fibrillation on Patients with Vascular Dementia: A Fundamental Target for Correct Management 189
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 187
Development of the optimal touchscreen interface for patients with scleroderma 187
Preface 182
SOFA and qSOFA usefulness for in-hospital death prediction of elderly patients admitted for suspected infection in internal medicine 178
Adalimumab modulates angiogenesis in psoriatic skin 174
Developments in the management of advanced soft-tissue sarcoma –€“ Olaratumab in context 173
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 172
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 165
SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study 163
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 159
6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study 159
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 159
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 153
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 152
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 149
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 148
Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs. 146
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 146
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 146
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 145
Analysis of ATP8B4 F436L missense variant in a large systemic sclerosis cohort 145
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 144
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 144
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients 143
Hypothalamic-pituitary-adrenal axis disregulation in PrPC-null mice. 143
Echocardiographic predictors of mortality in intermediate-risk pulmonary embolism 141
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach 137
Biologics in inflammatory immune-mediated systemic diseases 133
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter study 132
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 132
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 132
Agonistic antibodies in systemic sclerosis 132
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 131
Clusters of Comorbidities in the Short-Term Prognosis of Acute Heart Failure among Elderly Patients: A Retrospective Cohort Study 130
Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation 130
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 127
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 126
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 125
Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis 125
History and scientific production of clinica medica and clinica ematologica in ancona 124
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 124
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 122
Pathogenic autoantibodies in systemic sclerosis 121
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 121
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 120
Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation. 119
Update of EULAR recommendations for the treatment of systemic sclerosis 119
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 119
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 118
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 118
Mechanism of action of agonistic PDGFR auto-antibodies isolated from scleroderma patients 118
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 118
BIOLOGIC THERAPY IN INFLAMMATORY IMMUNOMEDIATED SYSTEMIC DISEASES: SAFETY PROFILE 118
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 117
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin 117
Putative functional pathogenic autoantibodies in systemic sclerosis 117
Clinical method applied to focused ultrasound: The case of wells’ score and echocardiography in the emergency department: A systematic review and a meta-analysis 117
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 116
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 116
Cutting-Edge Techniques and Drugs for the Treatment of Pulmonary Embolism: Current Knowledge and Future Perspectives 116
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 115
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 115
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 114
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 113
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 113
Implementation of EHMRG Risk Model in an Italian Population of Elderly Patients with Acute Heart Failure 112
MOTIF-GRAFTED HYBRID POLYPEPTIDES AND USES THEREOF 111
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 111
Detection of typical and atypical BSE and scrapie prion strains by prion protein motif-grafted antibodies. 110
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 109
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 109
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways 108
Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy 107
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectin. 107
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 105
Development of A Solid Phase Binding Assay For Detection of Conformational Anti-PDGFR Autoantibodies In the Serum of Patients Affected By Scleroderma 105
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 105
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 104
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 104
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 103
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 103
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort 102
Delection of typical and atypical bovine spongiform encephalopathy and scraipe prion strains by prion protein motif-grafted antibodies 102
Role of viral infections in the etiopathogenesis of systemic sclerosis 102
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 102
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 101
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 100
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 100
Development of a conformation-dependent immunoassay for the diagnosis of systemic sclerosis 99
The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index 98
Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study 98
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 97
Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress 96
Totale 13.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.867
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 0 0 0 0 0 0 75
2021/2022865 44 190 23 29 22 43 20 53 83 57 125 176
2022/20231.821 148 189 128 162 113 403 9 101 382 24 122 40
2023/20241.153 163 38 66 138 167 233 21 51 11 82 57 126
2024/20252.871 319 259 75 48 128 119 345 128 585 190 282 393
2025/20268.748 581 639 650 909 962 516 1.513 782 736 743 404 313
Totale 18.406